Hemofarm A.D. is a joint stock company with a Shareholders’ Assembly as its highest management body and a Chief Executive Officer elected by the Assembly.

A practice of offering equal chances to internal and external as well as local and international professionals is cherished when selecting members of top management.
Ronald Seeliger

Dr. Ronald Seeliger became the CEO of Hemofarm Group in 2012 and he has been a member of the STADA Group management since 2011.
Read whole biography


Orange positions represent Hemofarm AD

Purple pozitions represent STADA SCEE Cluster
Orange and blue positions represent Hemofarm Group

Orange-purple positions are in charge for purple markets also
Hemofarm A.D.
Beogradski put bb, 26300 Vršac, Serbia
tel +381 13 803 100, fax +381 13 803 100
Follow us: